These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37426837)

  • 1. The Effect of Hydroxychloroquine on In-Hospital Mortality in COVID-19.
    Aboulenain S; Dewaswala N; Ramos F; Torres P; Abdallah A; Qader MA; Al-Abbasi B; Bornmann CR; Dziadkowiec K; Chen K; Pino JE; Chait R; de Almeida K
    HCA Healthc J Med; 2020; 1():425-431. PubMed ID: 37426837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19.
    Tsanovska H; Simova I; Genov V; Kundurzhiev T; Krasnaliev J; Kornovski V; Dimitrov N; Vekov T
    Infect Disord Drug Targets; 2022; 22(6):e030322201650. PubMed ID: 35240966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study.
    Huang HD; Jneid H; Aziz M; Ravi V; Sharma PS; Larsen T; Chatterjee N; Saour B; Aziz Z; Nayak H; Trohman RG; Krishnan K
    Cardiol Ther; 2020 Dec; 9(2):523-534. PubMed ID: 33058086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study.
    Almazrou SH; Almalki ZS; Alanazi AS; Alqahtani AM; Alghamd SM
    Saudi Pharm J; 2020 Dec; 28(12):1877-1882. PubMed ID: 33020690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.
    Gasperetti A; Biffi M; Duru F; Schiavone M; Ziacchi M; Mitacchione G; Lavalle C; Saguner A; Lanfranchi A; Casalini G; Tocci M; Fabbricatore D; Salghetti F; Mariani MV; Busana M; Bellia A; Cogliati CB; Viale P; Antinori S; Galli M; Galiè N; Tondo C; Forleo GB
    Europace; 2020 Dec; 22(12):1855-1863. PubMed ID: 32971536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
    Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
    Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
    Padilla S; Telenti G; Guillén L; García JA; García-Abellán J; Ding C; Mora A; García-Pachón E; Gutiérrez F; Masiá M;
    Int J Antimicrob Agents; 2020 Oct; 56(4):106142. PubMed ID: 32853675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
    O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
    JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study.
    Alotaibi M; Ali A; Bakhshwin D; Alatawi Y; Alotaibi S; Alhifany A; Alharthi B; Alharthi N; Alyazidi A; Alharthi Y; Alrafiah A
    Int J Gen Med; 2021; 14():5597-5606. PubMed ID: 34548811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia.
    Alghamdi S; Barakat B; Berrou I; Alzahrani A; Haseeb A; Hammad MA; Anwar S; Sindi AAA; Almasmoum HA; Albanghali M
    Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33807320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydroxychloroquine treatment on QT interval.
    Hooks M; Bart B; Vardeny O; Westanmo A; Adabag S
    Heart Rhythm; 2020 Nov; 17(11):1930-1935. PubMed ID: 32610165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
    Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS
    PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "H" is not for hydroxychloroquine-"H" is for heparin: lack of efficacy of hydroxychloroquine and the role of heparin in COVID-19-preliminary data of a prospective and interventional study from Brazil.
    de Oliveira Costa R; Nascimento JS; Reichert CO; da Costa APA; Dos Santos MAP; Soares AM; Tomé CEM; Hayden RL; Dos Santos CW; Barreiro B; El-Khatib AAB; de Pádua Covas Lage LA; Pereira J; Benetti MM
    BMC Infect Dis; 2022 Feb; 22(1):120. PubMed ID: 35120461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19.
    Koh HM; Chong PF; Tan JN; Chidambaram SK; Chua HJ
    J Clin Pharm Ther; 2021 Jun; 46(3):800-806. PubMed ID: 33768612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ
    Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of Hydroxychloroquine and Azithromycin Combination Therapy on Hospital Mortality in COVID 19 Pneumonia Patients.
    Özuygur Ermiş SS; Ergan B; Kaçmaz Başoğlu Ö; Ercan S; Korkmaz Ekren P; Kuruüzüm Z; Özhan MH; Sayiner AA; Savran Y; Sertöz ŞR; Taşbakan MS; Kilinç O; Sayiner A
    Turk J Med Sci; 2021 Aug; ():. PubMed ID: 34344140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.